1.
Costanzo A, Furneri G, Bitonti R, Pedone MP, Fanelli F, Di Turi R. Cost-effectiveness analysis of dupilumab for the treatment of severe atopic dermatitis in adults in Italy: Analisi costo-utilità di dupilumab per il trattamento della dermatite atopica grave negli adulti in Italia. Grhta [Internet]. 2020 Aug. 24 [cited 2022 May 24];7(1):57-65. Available from: https://journals.aboutscience.eu/index.php/grhta/article/view/710